Table 1.2 Predictive variables for OS and PFS of 212 patients with HCC by univariate survival analysis (SYSUCC)

From: High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients

Variable

OS (months)

PFS (months)

Cases

HR(95% CI)

p value

HR(95% CI)

p value*

Age(years)

  

0.627

 

0.668

 ≤47.9#

105

1.0

1.0

 >47.9

107

1.092 (0.77–1.542)

1.061 (0.72–1.603)

Gender

  

0.045

 

0.058

 Male

174

1.651 (1.012–2.688)

1.352 (0.083–2.125)

 Female

38

1.0

1.0

Hepatitis history

  

0.810

 

0.524

 Yes

164

1.053 (0.692–1.602)

1.072 (0.059–1.633)

 No

48

1.0

1.0

AFP(ng/ml)

  

0.000

 

0.000

 ≤20

67

1.0

1.0

 >20

145

2.262 (1.490–3.434)

3.389 (2.157–4.886)

Tumor size(cm)

  

0.000

 

0.002

 ≤5

59

1.0

1.0

 >5

153

6.295 (3.688–10.747)

3.963 (2.597–5.559)

Tumor multiplicity

  

0.000

 

0.001

Single

128

1.0

1.0

Multiple

84

3.480 (2.429–4.987)

3.669 (2.582–5.139)

Stage

  

0.000

 

0.000

 I–II

88

1.0

1.0

 III–IV

124

5.393 (3.525–8.252)

4.847 (3.331–9.147)

Vascular invasion

  

0.000

 

0.000

 Yes

108

4.923 (3.331–7.322)

4.336 (3.139–6.736)

 No

104

1.0

1.0

PGAM5 expression

  

0.016

 

0.003

 Low

100

1.0

1.0

 High

112

3.165 (2.785–6.133)

4.391 (2.336–8.461)

  1. #mean age
  2. *Log-rank test